Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $46000.0.

  • International Stem Cell's Net Cash Flow fell 7880.18% to $46000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$141000.0, marking a year-over-year decrease of 28311.69%. This contributed to the annual value of -$358000.0 for FY2024, which is 14231.68% down from last year.
  • International Stem Cell's Net Cash Flow amounted to $46000.0 in Q3 2025, which was down 7880.18% from -$332000.0 recorded in Q2 2025.
  • International Stem Cell's Net Cash Flow's 5-year high stood at $439000.0 during Q2 2023, with a 5-year trough of -$367000.0 in Q2 2021.
  • Over the past 5 years, International Stem Cell's median Net Cash Flow value was $76000.0 (recorded in 2022), while the average stood at $35842.1.
  • In the last 5 years, International Stem Cell's Net Cash Flow crashed by 68085.11% in 2021 and then soared by 35208.33% in 2024.
  • Quarter analysis of 5 years shows International Stem Cell's Net Cash Flow stood at -$334000.0 in 2021, then soared by 122.75% to $76000.0 in 2022, then soared by 107.89% to $158000.0 in 2023, then tumbled by 148.73% to -$77000.0 in 2024, then soared by 159.74% to $46000.0 in 2025.
  • Its Net Cash Flow was $46000.0 in Q3 2025, compared to -$332000.0 in Q2 2025 and $222000.0 in Q1 2025.